Opioid treatment receives $377m funding increase The measure, included in this week’s Federal Budget, will ‘save lives’, according to the RACGP President.
Codeine use down by 37% since up-scheduling Use of the drug has dropped substantially across all jurisdictions, a new wastewater-based epidemiology report suggests.
Concerns over growing misuse of Rikodeine cough medicine The addictive cough suppressant is popular among young people, more potent than codeine, and poses a serious risk of harm.
Providing help that is needed but not wanted Dr Thileepan Naren’s choice to persevere with a patient during their recovery from opioid addiction led to triumphant outcomes.
How can opioid deaths be reduced? New studies further verify the benefits of pharmacotherapy for opioid dependence in greatly reducing all-cause mortality rates.
Who is seeking pharmacotherapy treatment for opioid dependence? Annual data examines who, where and why on a ‘snapshot day’ in 2020, and how treatment has progressed.
Mundipharma fined for misleading advertising of opioids The international affiliate of Purdue Pharma was issued 24 infringement notices by the Therapeutic Goods Administration.
New patient guide aims to reduce opioid harms A lack of information regarding opioid use after hospital discharge can be dangerous for some patients, but a new guide aims to close that gap.
Advocates hail ‘game changing’ PBS listing of buprenorphine Harm-reduction advocates have long called for an end to the surprisingly high cost of opioid substitution therapy.
Hospital to introduce opioid plan to tackle risk of post-surgery dependence A Perth hospital will move to introduce opioid-weaning plans for post-surgery patients in a bid to address rising rates of opioid dependency.